ARTICLE | Clinical News
Hematopoietic stem cells: Started Phase III study
October 29, 2001 8:00 AM UTC
Nexell Therapeutics Inc. (NEXL), Irvine, Calif. Product: Hematopoietic stem cells Business: Gene/Cell therapy Therapeutic category: Cell replacement Target: NA Description: Hematopoeitic stem cells de...